Greater Value Portfolio

Greater Value Portfolio Grant Program

CLOSED!

In 2021, the Donaghue Foundation’s Greater Value Portfolio grant program will fund research projects for two years with a maximum amount of $400,000 per award for the purpose of advancing promising approaches to achieve a higher value healthcare system. The goal of this program is to test approaches and tools that organizations can readily use to improve the value of the healthcare they provide to their patients and communities.

Investigators conducting research to develop actionable solutions to one or more of these symptoms of low value healthcare are encouraged to apply to the Greater Value Portfolio program:

  • High and rising healthcare costs
  • Unwarranted variation in prices,
  • Racial and ethnic disparities in access, prices and outcomes
  • Unaffordable cost of care burden on patients and families
  • Unacceptable variation in quality
  • Lack of transparency in both price and outcomes

Investigators conducting research to develop actionable solutions to one or more of these symptoms of low value healthcare are encouraged to apply to the Greater Value Portfolio program.

Eligible topics include studies that focus on improving value through promising strategies using one or more of these approaches:

  • Test models of care, coverage or system change that  seek to improve value by addressing one or more of the symptoms of low value
  • Reduce treatments, tests, and screenings for patients for whom the potential harms (including financial harm) outweigh potential benefits
  • Provide tools to help consumers make decisions about their healthcare based on value, including the cost of care to patients, in addition to other patient-centered factors
  • Promote conversations between patients and their clinicians and care teams about preferences and trade-offs related to alternative treatment options and /or out of pocket cost burden to patients and families
  • Test interventions geared to increasing equity through the provision of higher value healthcare

In all programs, the Foundation requires applicants to demonstrate that they have reviewed their research questions, protocols, sampling, and data analyses to ensure that they do not inadvertently mask or exacerbate racial, ethnic or gender health inequities.

Eligibility Criteria

This program is open to PhD (or equivalent) investigators at tax-exempt research institutions in the United States. In order to receive an award, the applicant must partner with an organization that delivers healthcare services or be a researcher based in a research unit embedded in a healthcare organization. Partner organizations cannot be the applicant organization. A fuller description of eligible applicant institutions is in the detailed program description below. Grantees may use this award to augment funding for a project already funded through another grant.

Applicant organization must be 501(c)3 research institutions. Donaghue requires that the applicant organization has adequate infrastructure to assure:

  • Ethical conduct of research, protection of research participants, and appropriate data protections
  • Financial monitoring of grant awards and administering any related subcontracts
  • Resources to assist the principal investigator with dissemination activities

Additional material may be requested at the letter of intent stage from applicants whose organization does not have clear evidence of these capacities on their website.

Timeline for Application Process

April 26, 2021                                     Letters of intent due
June 4, 2021                                        Notice of LOI decision
July 30, 2021                                       Applications due
January 2022                                      Grant term begins


How To Apply

Greater Value Portfolio Grant Announcement
Greater Value Portfolio Letter of Intent Instructions & Form
Greater Value Portfolio Application Instructions
Greater Value Portfolio Application Forms

Frequently Asked Questions

UPDATE– Another Look and Greater Value Portfolio Information Session (video)

 

 

Awardees

 



2021

William Dale, MD, PhD
City of Hope
“Geriatric Assessment-Drive Supportive Care Interventions to Reduce Low-value Care in Older Adults with Cancer in the Community”
Partnering organization: City of Hope (multiple campuses)

Mark D. Neuman, MD, MSc
University of Pennsylvania
“Accelerating de-adoption of low-value care for older surgical patients through behavioral economics and patient empowerment”
Partnering organization: US Anesthesia Partners

Rachel L. Epstein, MD, MSc
Boston Medical Center
“Cost-effectiveness and Clinical Outcomes of Liver Disease Staging Evaluations in Chronic Hepatitis C Virus (HCV) Infection: Strategies to Increase Hepatitis C Treatment Access and Achieve HCV Elimination”
Partnering organization(s): National Viral Hepatitis Roundtable, Center for Health Economics of Treatment
Interventions for Substance Use Disorder, HCV, and HIV, and the Rhode Island Department of
Health

Anna Sick-Samuels, MD, MPH
Johns Hopkins University
“Reducing overuse of respiratory cultures and antibiotic use in mechanically ventilated children across a national pediatric critical care collaborative”
Partnering organization(s): Children’s Hospital of Philadelphia and Boston Children’s
Hospital

Cassandra Thiel, PhD
NYU Grossman School of Medicine
“Increasing Value through Optimized Cataract Surgical Care Pathways and Supply”
Partnering organization: NYU Langone Eye Center


2020

Hannah Cohen-Cline, PhD
Providence Health Services
“Does a Rising Tide Lift All Boats? Assessing the Direct and Indirect Effects of APMs in Primary Care”
Partner Organization: Care Oregon

Megan Cole, PhD, MPH and June-Ho Kim, MD, MPH
Boston University School of Public Health
“Value and Equity of Telehealth for Low-Income Patients with Chronic Conditions at Federally Qualified Health Centers”
Partner Organization: Community Care Cooperative

Fasika Woreta, MD
Johns Hopkins
“Real-time prescription benefit tools in the electronic health record: working towards greater value for prescribers and patients”
Partner Organizations: Froedtert and Medical College of Wisconsin, Yale New Haven Health System, Johns Hopkins Health System


2019

Laura F. Garabedian, PhD, MPH
Harvard Pilgrim Health Care Institute
“Impact of an Innovative Payer-Provider Joint Venture on Health Care Value”
Partner Organization: Benevera Health

Mary E. Tinetti, MD
Yale School of Medicine
“Reducing Unwanted Care and Improving Outcomes by Aligning Care with the Health Priorities of Older Adults with Multiple Chronic Conditions”
Partner Organization: Cleveland Clinic Center for Geriatric Medicine

Malini Nijagal, MD, MPH and Courtney Lyles, PhD
University of California San Francisco Medical School
“The Use of Telemedicine to Achieve Higher Value Pregnancy Care for Low‐income, Urban Women”
Partner Organization: San Francisco Health Network

Scott E. Regenbogen, MD, MPH
University of Michigan
“Hospital Strategies for Success in Episode-based Hospital Reimbursement”
Partner Organization: Michigan Value Collaborative


2018

Bryan Dowd, PhD
University of Minnesota
“Incorporating Quality of Care Information into a Tiered Cost-sharing Health Insurance Benefit”
Partner organization: State of Minnesota

Kai Yeung, PharmD, PhD
Kaiser Permanente Washington Health Research Institute
“Value-based Formulary-Essentials: Testing and Expanding on Value in Prescription Drug Benefit Design”
Partner organization: Premera Blue Cross

Sapna R. Kudchadkar, MD, PhD
Johns Hopkins University
Impact of a Multifaceted Early Mobility intervention on Clinical Outcomes and ICU-acquired Morbidities in Critically Ill children”
Partner organizations: Children’s Hospital, St. Petersburg, Florida; Our Lady of the Lake Children’s Hospital, Baton Rouge, Louisiana; Advocate Children’s Hospital, Park Ridge, Illinois; Boston Children’s Hospital

Nadine Jackson McCleary, BSN MD MPH
Dana Farber Cancer Institute
“Assessing toxicity and adherence of oral cancer therapy with ePROs”
Partner Organization: Dana Farber Cancer Institute

 


2017

Amol Navathe, MD, PhD
Mitesh S. Patel, MD
The University of Pennsylvania
“The REDUCE Trial‐ Randomized trial of EHR Defaults and Using social Comparison feedback to Effectively decrease opioid prescription pill burden”

Peter Ubel, MD
Duke University
“Examining Best Practices for Factoring Out-Of-Pocket Expenses into Patients’ Health Care Decisions”

 

 

Jennifer Raymond, MD, MCR
Children’s Hospital Los Angeles
“CoYoT1 to California (CTC) – Telemedicine to Engage Young Adults with Diabetes”

Karen Sepucha, PhD
Massachusetts General Hospital
“Matching the right person to the right treatment: Shared decision making for high cost elective procedures”


2016 – funded in partnership with the Rx Foundation

Scott Halpern, MD, PhD
University of Pennsylvania
“Behavioral Economics Approaches to Improve Palliative Care for Critically Ill Patients”

Sophia Jan, MD, MSHP
The Feinstein Institute for Medical Research
“Long Term Care Planning for Adults with Intellectual/Developmental Disabilities”

Ateev Mehrotra, MD, MPH
Harvard University
“Just Google It: What is the Impact of Health Care Price Information Being More Accessible to Consumers?”

David Meltzer, MD, PhD
University of Chicago
“Longitudinal Effects of the Comprehensive Care Physician Program”


2015

Jeffrey T. Kullgren, MD, MPH and Eve A. Kerr, MD, MPH
University of Michigan
“Patient, Provider, and Health System Effects of Provider Commitments to Choosing Wisely”

Valerie A. Lewis, PhD
Geisel School of Medicine at Dartmouth College
“Demonstrating Methods to Integrate Clinical Care, Public Health, and Social Services with Value-Based Payment Models”

Dale Ellen Lupu, PhD MPH
George Washington University
“Implementing Shared-Decision Making with Chronic Kidney Disease: Testing its impact on improved quality of life and reduced health care costs”